nodes	percent_of_prediction	percent_of_DWPC	metapath
Sparfloxacin—ABCB1—colon cancer	0.467	1	CbGaD
Sparfloxacin—ABCC2—Irinotecan—colon cancer	0.115	0.314	CbGbCtD
Sparfloxacin—ABCC2—Vincristine—colon cancer	0.101	0.274	CbGbCtD
Sparfloxacin—ABCC2—Methotrexate—colon cancer	0.061	0.166	CbGbCtD
Sparfloxacin—ABCB1—Irinotecan—colon cancer	0.0376	0.102	CbGbCtD
Sparfloxacin—ABCB1—Vincristine—colon cancer	0.0328	0.0894	CbGbCtD
Sparfloxacin—ABCB1—Methotrexate—colon cancer	0.0199	0.0541	CbGbCtD
Sparfloxacin—ABCC2—bile—colon cancer	0.00603	0.383	CbGeAlD
Sparfloxacin—TOP2A—Topotecan—Irinotecan—colon cancer	0.00196	0.404	CbGdCrCtD
Sparfloxacin—TOP2A—Vindesine—Vincristine—colon cancer	0.0014	0.289	CbGdCrCtD
Sparfloxacin—TOP2A—bone marrow—colon cancer	0.000888	0.0564	CbGeAlD
Sparfloxacin—TOP2A—Vinorelbine—Vincristine—colon cancer	0.000884	0.182	CbGdCrCtD
Sparfloxacin—TOP2A—vagina—colon cancer	0.00085	0.0541	CbGeAlD
Sparfloxacin—ABCC2—renal system—colon cancer	0.000803	0.051	CbGeAlD
Sparfloxacin—ABCC2—digestive system—colon cancer	0.000658	0.0418	CbGeAlD
Sparfloxacin—ABCB1—blood vessel—colon cancer	0.000639	0.0406	CbGeAlD
Sparfloxacin—SLC22A5—renal system—colon cancer	0.000622	0.0395	CbGeAlD
Sparfloxacin—TOP2A—Vinblastine—Vincristine—colon cancer	0.000608	0.125	CbGdCrCtD
Sparfloxacin—TOP2A—lymph node—colon cancer	0.00055	0.035	CbGeAlD
Sparfloxacin—SLC22A5—digestive system—colon cancer	0.00051	0.0324	CbGeAlD
Sparfloxacin—ABCC2—liver—colon cancer	0.00049	0.0312	CbGeAlD
Sparfloxacin—SLC22A5—vagina—colon cancer	0.00045	0.0286	CbGeAlD
Sparfloxacin—ABCB1—embryo—colon cancer	0.000381	0.0242	CbGeAlD
Sparfloxacin—SLC22A5—liver—colon cancer	0.00038	0.0242	CbGeAlD
Sparfloxacin—ABCC2—lymph node—colon cancer	0.000376	0.0239	CbGeAlD
Sparfloxacin—Urinary retention—Capecitabine—colon cancer	0.000339	0.00235	CcSEcCtD
Sparfloxacin—Mood swings—Capecitabine—colon cancer	0.000338	0.00234	CcSEcCtD
Sparfloxacin—Ataxia—Capecitabine—colon cancer	0.000335	0.00232	CcSEcCtD
Sparfloxacin—Alopecia—Vincristine—colon cancer	0.000334	0.00232	CcSEcCtD
Sparfloxacin—Chills—Irinotecan—colon cancer	0.000331	0.00229	CcSEcCtD
Sparfloxacin—Mouth ulceration—Methotrexate—colon cancer	0.000331	0.00229	CcSEcCtD
Sparfloxacin—Urine output increased—Methotrexate—colon cancer	0.000331	0.00229	CcSEcCtD
Sparfloxacin—Ecchymosis—Methotrexate—colon cancer	0.000331	0.00229	CcSEcCtD
Sparfloxacin—Arrhythmia—Irinotecan—colon cancer	0.000329	0.00228	CcSEcCtD
Sparfloxacin—Dry skin—Capecitabine—colon cancer	0.000327	0.00226	CcSEcCtD
Sparfloxacin—Alopecia—Irinotecan—colon cancer	0.000326	0.00226	CcSEcCtD
Sparfloxacin—Orthostatic hypotension—Capecitabine—colon cancer	0.000326	0.00226	CcSEcCtD
Sparfloxacin—Abdominal pain upper—Capecitabine—colon cancer	0.000326	0.00226	CcSEcCtD
Sparfloxacin—Pulmonary oedema—Methotrexate—colon cancer	0.000325	0.00226	CcSEcCtD
Sparfloxacin—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.000321	0.00222	CcSEcCtD
Sparfloxacin—Back pain—Vincristine—colon cancer	0.000319	0.00221	CcSEcCtD
Sparfloxacin—Flatulence—Irinotecan—colon cancer	0.000316	0.00219	CcSEcCtD
Sparfloxacin—Arrhythmia—Fluorouracil—colon cancer	0.000315	0.00218	CcSEcCtD
Sparfloxacin—Alanine aminotransferase increased—Capecitabine—colon cancer	0.000314	0.00218	CcSEcCtD
Sparfloxacin—Alopecia—Fluorouracil—colon cancer	0.000312	0.00216	CcSEcCtD
Sparfloxacin—ABCB1—epithelium—colon cancer	0.000311	0.0198	CbGeAlD
Sparfloxacin—Lymphadenopathy—Methotrexate—colon cancer	0.000311	0.00216	CcSEcCtD
Sparfloxacin—Back pain—Irinotecan—colon cancer	0.00031	0.00215	CcSEcCtD
Sparfloxacin—Asthma—Capecitabine—colon cancer	0.000308	0.00214	CcSEcCtD
Sparfloxacin—Agitation—Vincristine—colon cancer	0.000303	0.0021	CcSEcCtD
Sparfloxacin—Polyuria—Methotrexate—colon cancer	0.000302	0.00209	CcSEcCtD
Sparfloxacin—Angina pectoris—Capecitabine—colon cancer	0.0003	0.00208	CcSEcCtD
Sparfloxacin—Ill-defined disorder—Irinotecan—colon cancer	0.000298	0.00206	CcSEcCtD
Sparfloxacin—Bronchitis—Capecitabine—colon cancer	0.000296	0.00205	CcSEcCtD
Sparfloxacin—Vertigo—Vincristine—colon cancer	0.000296	0.00205	CcSEcCtD
Sparfloxacin—Hepatic failure—Methotrexate—colon cancer	0.000295	0.00205	CcSEcCtD
Sparfloxacin—Pancytopenia—Capecitabine—colon cancer	0.000293	0.00203	CcSEcCtD
Sparfloxacin—SLC22A5—lymph node—colon cancer	0.000291	0.0185	CbGeAlD
Sparfloxacin—Malaise—Irinotecan—colon cancer	0.000289	0.002	CcSEcCtD
Sparfloxacin—ABCB1—renal system—colon cancer	0.000289	0.0183	CbGeAlD
Sparfloxacin—Vertigo—Irinotecan—colon cancer	0.000288	0.002	CcSEcCtD
Sparfloxacin—Dysuria—Capecitabine—colon cancer	0.000288	0.002	CcSEcCtD
Sparfloxacin—Renal failure acute—Methotrexate—colon cancer	0.000288	0.00199	CcSEcCtD
Sparfloxacin—Convulsion—Vincristine—colon cancer	0.000285	0.00198	CcSEcCtD
Sparfloxacin—Hypertension—Vincristine—colon cancer	0.000284	0.00197	CcSEcCtD
Sparfloxacin—Dermatitis exfoliative—Methotrexate—colon cancer	0.000281	0.00195	CcSEcCtD
Sparfloxacin—Photosensitivity reaction—Capecitabine—colon cancer	0.000281	0.00195	CcSEcCtD
Sparfloxacin—Myalgia—Vincristine—colon cancer	0.00028	0.00194	CcSEcCtD
Sparfloxacin—Cough—Irinotecan—colon cancer	0.00028	0.00194	CcSEcCtD
Sparfloxacin—Hypertension—Irinotecan—colon cancer	0.000277	0.00192	CcSEcCtD
Sparfloxacin—Pneumonia—Capecitabine—colon cancer	0.000276	0.00192	CcSEcCtD
Sparfloxacin—Anaphylactoid reaction—Methotrexate—colon cancer	0.000274	0.0019	CcSEcCtD
Sparfloxacin—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.000272	0.00189	CcSEcCtD
Sparfloxacin—Discomfort—Irinotecan—colon cancer	0.00027	0.00187	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Vincristine—colon cancer	0.000269	0.00186	CcSEcCtD
Sparfloxacin—Jaundice—Capecitabine—colon cancer	0.000268	0.00186	CcSEcCtD
Sparfloxacin—Stomatitis—Capecitabine—colon cancer	0.000268	0.00186	CcSEcCtD
Sparfloxacin—Urinary tract infection—Capecitabine—colon cancer	0.000267	0.00185	CcSEcCtD
Sparfloxacin—Conjunctivitis—Capecitabine—colon cancer	0.000267	0.00185	CcSEcCtD
Sparfloxacin—Convulsion—Fluorouracil—colon cancer	0.000266	0.00184	CcSEcCtD
Sparfloxacin—Osteoarthritis—Methotrexate—colon cancer	0.000265	0.00184	CcSEcCtD
Sparfloxacin—Confusional state—Irinotecan—colon cancer	0.000264	0.00183	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Vincristine—colon cancer	0.000263	0.00182	CcSEcCtD
Sparfloxacin—Haematuria—Capecitabine—colon cancer	0.000262	0.00182	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Irinotecan—colon cancer	0.000262	0.00181	CcSEcCtD
Sparfloxacin—Chest pain—Fluorouracil—colon cancer	0.000262	0.00181	CcSEcCtD
Sparfloxacin—Myalgia—Fluorouracil—colon cancer	0.000262	0.00181	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Vincristine—colon cancer	0.00026	0.0018	CcSEcCtD
Sparfloxacin—Epistaxis—Capecitabine—colon cancer	0.000259	0.0018	CcSEcCtD
Sparfloxacin—Discomfort—Fluorouracil—colon cancer	0.000258	0.00179	CcSEcCtD
Sparfloxacin—Agranulocytosis—Capecitabine—colon cancer	0.000256	0.00178	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Irinotecan—colon cancer	0.000256	0.00178	CcSEcCtD
Sparfloxacin—Anorexia—Vincristine—colon cancer	0.000256	0.00178	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Irinotecan—colon cancer	0.000253	0.00175	CcSEcCtD
Sparfloxacin—Confusional state—Fluorouracil—colon cancer	0.000253	0.00175	CcSEcCtD
Sparfloxacin—Mood swings—Methotrexate—colon cancer	0.000251	0.00174	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Fluorouracil—colon cancer	0.000251	0.00174	CcSEcCtD
Sparfloxacin—Anorexia—Irinotecan—colon cancer	0.00025	0.00173	CcSEcCtD
Sparfloxacin—Ataxia—Methotrexate—colon cancer	0.00025	0.00173	CcSEcCtD
Sparfloxacin—Haemoglobin—Capecitabine—colon cancer	0.000248	0.00172	CcSEcCtD
Sparfloxacin—Rhinitis—Capecitabine—colon cancer	0.000247	0.00171	CcSEcCtD
Sparfloxacin—Hepatitis—Capecitabine—colon cancer	0.000247	0.00171	CcSEcCtD
Sparfloxacin—Haemorrhage—Capecitabine—colon cancer	0.000247	0.00171	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Fluorouracil—colon cancer	0.000246	0.0017	CcSEcCtD
Sparfloxacin—Hypoaesthesia—Capecitabine—colon cancer	0.000245	0.0017	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Vincristine—colon cancer	0.000245	0.0017	CcSEcCtD
Sparfloxacin—Pharyngitis—Capecitabine—colon cancer	0.000245	0.0017	CcSEcCtD
Sparfloxacin—Tachycardia—Fluorouracil—colon cancer	0.000245	0.0017	CcSEcCtD
Sparfloxacin—Insomnia—Vincristine—colon cancer	0.000243	0.00168	CcSEcCtD
Sparfloxacin—Oedema peripheral—Capecitabine—colon cancer	0.000243	0.00168	CcSEcCtD
Sparfloxacin—Paraesthesia—Vincristine—colon cancer	0.000241	0.00167	CcSEcCtD
Sparfloxacin—ABCB1—lymphoid tissue—colon cancer	0.00024	0.0152	CbGeAlD
Sparfloxacin—Anorexia—Fluorouracil—colon cancer	0.000239	0.00166	CcSEcCtD
Sparfloxacin—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000239	0.00166	CcSEcCtD
Sparfloxacin—Insomnia—Irinotecan—colon cancer	0.000237	0.00164	CcSEcCtD
Sparfloxacin—ABCB1—digestive system—colon cancer	0.000237	0.015	CbGeAlD
Sparfloxacin—Paraesthesia—Irinotecan—colon cancer	0.000235	0.00163	CcSEcCtD
Sparfloxacin—Decreased appetite—Vincristine—colon cancer	0.000234	0.00162	CcSEcCtD
Sparfloxacin—Dyspnoea—Irinotecan—colon cancer	0.000233	0.00162	CcSEcCtD
Sparfloxacin—Erythema multiforme—Capecitabine—colon cancer	0.000233	0.00162	CcSEcCtD
Sparfloxacin—Somnolence—Irinotecan—colon cancer	0.000233	0.00161	CcSEcCtD
Sparfloxacin—Dyspepsia—Irinotecan—colon cancer	0.000231	0.0016	CcSEcCtD
Sparfloxacin—Tinnitus—Capecitabine—colon cancer	0.00023	0.00159	CcSEcCtD
Sparfloxacin—Constipation—Vincristine—colon cancer	0.00023	0.00159	CcSEcCtD
Sparfloxacin—Pain—Vincristine—colon cancer	0.00023	0.00159	CcSEcCtD
Sparfloxacin—Asthma—Methotrexate—colon cancer	0.000229	0.00159	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000228	0.00158	CcSEcCtD
Sparfloxacin—Decreased appetite—Irinotecan—colon cancer	0.000228	0.00158	CcSEcCtD
Sparfloxacin—Insomnia—Fluorouracil—colon cancer	0.000227	0.00157	CcSEcCtD
Sparfloxacin—Paraesthesia—Fluorouracil—colon cancer	0.000225	0.00156	CcSEcCtD
Sparfloxacin—Pancreatitis—Methotrexate—colon cancer	0.000225	0.00156	CcSEcCtD
Sparfloxacin—Pain—Irinotecan—colon cancer	0.000224	0.00155	CcSEcCtD
Sparfloxacin—Constipation—Irinotecan—colon cancer	0.000224	0.00155	CcSEcCtD
Sparfloxacin—Dyspnoea—Fluorouracil—colon cancer	0.000224	0.00155	CcSEcCtD
Sparfloxacin—Somnolence—Fluorouracil—colon cancer	0.000223	0.00154	CcSEcCtD
Sparfloxacin—Chills—Capecitabine—colon cancer	0.000221	0.00153	CcSEcCtD
Sparfloxacin—Dyspepsia—Fluorouracil—colon cancer	0.000221	0.00153	CcSEcCtD
Sparfloxacin—Arrhythmia—Capecitabine—colon cancer	0.00022	0.00153	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Vincristine—colon cancer	0.00022	0.00152	CcSEcCtD
Sparfloxacin—Levofloxacin—ABCB1—colon cancer	0.00022	0.509	CrCbGaD
Sparfloxacin—ABCB1—bone marrow—colon cancer	0.000218	0.0139	CbGeAlD
Sparfloxacin—Decreased appetite—Fluorouracil—colon cancer	0.000218	0.00151	CcSEcCtD
Sparfloxacin—Alopecia—Capecitabine—colon cancer	0.000218	0.00151	CcSEcCtD
Sparfloxacin—Pancytopenia—Methotrexate—colon cancer	0.000218	0.00151	CcSEcCtD
Sparfloxacin—Feeling abnormal—Irinotecan—colon cancer	0.000216	0.0015	CcSEcCtD
Sparfloxacin—Dysuria—Methotrexate—colon cancer	0.000215	0.00149	CcSEcCtD
Sparfloxacin—Pain—Fluorouracil—colon cancer	0.000214	0.00149	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Irinotecan—colon cancer	0.000214	0.00148	CcSEcCtD
Sparfloxacin—Abdominal pain—Vincristine—colon cancer	0.000213	0.00147	CcSEcCtD
Sparfloxacin—Body temperature increased—Vincristine—colon cancer	0.000213	0.00147	CcSEcCtD
Sparfloxacin—Ciprofloxacin—ABCB1—colon cancer	0.000212	0.491	CrCbGaD
Sparfloxacin—Flatulence—Capecitabine—colon cancer	0.000212	0.00147	CcSEcCtD
Sparfloxacin—Dysgeusia—Capecitabine—colon cancer	0.00021	0.00146	CcSEcCtD
Sparfloxacin—Photosensitivity reaction—Methotrexate—colon cancer	0.000209	0.00145	CcSEcCtD
Sparfloxacin—ABCB1—vagina—colon cancer	0.000209	0.0133	CbGeAlD
Sparfloxacin—Back pain—Capecitabine—colon cancer	0.000208	0.00144	CcSEcCtD
Sparfloxacin—Body temperature increased—Irinotecan—colon cancer	0.000207	0.00143	CcSEcCtD
Sparfloxacin—Abdominal pain—Irinotecan—colon cancer	0.000207	0.00143	CcSEcCtD
Sparfloxacin—Feeling abnormal—Fluorouracil—colon cancer	0.000207	0.00143	CcSEcCtD
Sparfloxacin—Pneumonia—Methotrexate—colon cancer	0.000206	0.00143	CcSEcCtD
Sparfloxacin—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000203	0.00141	CcSEcCtD
Sparfloxacin—Tremor—Capecitabine—colon cancer	0.000201	0.00139	CcSEcCtD
Sparfloxacin—Stomatitis—Methotrexate—colon cancer	0.000199	0.00138	CcSEcCtD
Sparfloxacin—Ill-defined disorder—Capecitabine—colon cancer	0.000199	0.00138	CcSEcCtD
Sparfloxacin—Urticaria—Fluorouracil—colon cancer	0.000199	0.00138	CcSEcCtD
Sparfloxacin—Conjunctivitis—Methotrexate—colon cancer	0.000199	0.00138	CcSEcCtD
Sparfloxacin—Body temperature increased—Fluorouracil—colon cancer	0.000198	0.00137	CcSEcCtD
Sparfloxacin—Hypersensitivity—Vincristine—colon cancer	0.000198	0.00137	CcSEcCtD
Sparfloxacin—Sweating—Methotrexate—colon cancer	0.000196	0.00136	CcSEcCtD
Sparfloxacin—Haematuria—Methotrexate—colon cancer	0.000195	0.00135	CcSEcCtD
Sparfloxacin—Malaise—Capecitabine—colon cancer	0.000194	0.00134	CcSEcCtD
Sparfloxacin—Epistaxis—Methotrexate—colon cancer	0.000193	0.00134	CcSEcCtD
Sparfloxacin—Vertigo—Capecitabine—colon cancer	0.000193	0.00134	CcSEcCtD
Sparfloxacin—Hypersensitivity—Irinotecan—colon cancer	0.000193	0.00134	CcSEcCtD
Sparfloxacin—Asthenia—Vincristine—colon cancer	0.000193	0.00134	CcSEcCtD
Sparfloxacin—Agranulocytosis—Methotrexate—colon cancer	0.000191	0.00132	CcSEcCtD
Sparfloxacin—Palpitations—Capecitabine—colon cancer	0.00019	0.00131	CcSEcCtD
Sparfloxacin—Asthenia—Irinotecan—colon cancer	0.000188	0.0013	CcSEcCtD
Sparfloxacin—Cough—Capecitabine—colon cancer	0.000187	0.0013	CcSEcCtD
Sparfloxacin—Hypertension—Capecitabine—colon cancer	0.000185	0.00128	CcSEcCtD
Sparfloxacin—Hypersensitivity—Fluorouracil—colon cancer	0.000185	0.00128	CcSEcCtD
Sparfloxacin—Haemoglobin—Methotrexate—colon cancer	0.000185	0.00128	CcSEcCtD
Sparfloxacin—Diarrhoea—Vincristine—colon cancer	0.000184	0.00127	CcSEcCtD
Sparfloxacin—Hepatitis—Methotrexate—colon cancer	0.000184	0.00127	CcSEcCtD
Sparfloxacin—Haemorrhage—Methotrexate—colon cancer	0.000184	0.00127	CcSEcCtD
Sparfloxacin—Arthralgia—Capecitabine—colon cancer	0.000183	0.00127	CcSEcCtD
Sparfloxacin—Myalgia—Capecitabine—colon cancer	0.000183	0.00127	CcSEcCtD
Sparfloxacin—Chest pain—Capecitabine—colon cancer	0.000183	0.00127	CcSEcCtD
Sparfloxacin—Pharyngitis—Methotrexate—colon cancer	0.000182	0.00126	CcSEcCtD
Sparfloxacin—Anxiety—Capecitabine—colon cancer	0.000182	0.00126	CcSEcCtD
Sparfloxacin—Discomfort—Capecitabine—colon cancer	0.000181	0.00125	CcSEcCtD
Sparfloxacin—Diarrhoea—Irinotecan—colon cancer	0.000179	0.00124	CcSEcCtD
Sparfloxacin—Dry mouth—Capecitabine—colon cancer	0.000179	0.00124	CcSEcCtD
Sparfloxacin—Dizziness—Vincristine—colon cancer	0.000178	0.00123	CcSEcCtD
Sparfloxacin—Pruritus—Fluorouracil—colon cancer	0.000177	0.00123	CcSEcCtD
Sparfloxacin—Confusional state—Capecitabine—colon cancer	0.000177	0.00122	CcSEcCtD
Sparfloxacin—ABCB1—liver—colon cancer	0.000176	0.0112	CbGeAlD
Sparfloxacin—Erythema multiforme—Methotrexate—colon cancer	0.000174	0.0012	CcSEcCtD
Sparfloxacin—Dizziness—Irinotecan—colon cancer	0.000173	0.0012	CcSEcCtD
Sparfloxacin—Diarrhoea—Fluorouracil—colon cancer	0.000172	0.00119	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Capecitabine—colon cancer	0.000172	0.00119	CcSEcCtD
Sparfloxacin—Tinnitus—Methotrexate—colon cancer	0.000171	0.00119	CcSEcCtD
Sparfloxacin—Tachycardia—Capecitabine—colon cancer	0.000171	0.00119	CcSEcCtD
Sparfloxacin—Vomiting—Vincristine—colon cancer	0.000171	0.00118	CcSEcCtD
Sparfloxacin—Rash—Vincristine—colon cancer	0.00017	0.00117	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Capecitabine—colon cancer	0.000169	0.00117	CcSEcCtD
Sparfloxacin—Dermatitis—Vincristine—colon cancer	0.000169	0.00117	CcSEcCtD
Sparfloxacin—Headache—Vincristine—colon cancer	0.000168	0.00117	CcSEcCtD
Sparfloxacin—Anorexia—Capecitabine—colon cancer	0.000167	0.00116	CcSEcCtD
Sparfloxacin—Vomiting—Irinotecan—colon cancer	0.000166	0.00115	CcSEcCtD
Sparfloxacin—Dizziness—Fluorouracil—colon cancer	0.000166	0.00115	CcSEcCtD
Sparfloxacin—Rash—Irinotecan—colon cancer	0.000165	0.00114	CcSEcCtD
Sparfloxacin—Dermatitis—Irinotecan—colon cancer	0.000165	0.00114	CcSEcCtD
Sparfloxacin—Chills—Methotrexate—colon cancer	0.000165	0.00114	CcSEcCtD
Sparfloxacin—Headache—Irinotecan—colon cancer	0.000164	0.00114	CcSEcCtD
Sparfloxacin—Alopecia—Methotrexate—colon cancer	0.000162	0.00112	CcSEcCtD
Sparfloxacin—Nausea—Vincristine—colon cancer	0.00016	0.00111	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00016	0.00111	CcSEcCtD
Sparfloxacin—Vomiting—Fluorouracil—colon cancer	0.000159	0.0011	CcSEcCtD
Sparfloxacin—Insomnia—Capecitabine—colon cancer	0.000159	0.0011	CcSEcCtD
Sparfloxacin—Rash—Fluorouracil—colon cancer	0.000158	0.0011	CcSEcCtD
Sparfloxacin—Dermatitis—Fluorouracil—colon cancer	0.000158	0.00109	CcSEcCtD
Sparfloxacin—Paraesthesia—Capecitabine—colon cancer	0.000157	0.00109	CcSEcCtD
Sparfloxacin—Headache—Fluorouracil—colon cancer	0.000157	0.00109	CcSEcCtD
Sparfloxacin—Dysgeusia—Methotrexate—colon cancer	0.000157	0.00108	CcSEcCtD
Sparfloxacin—Dyspnoea—Capecitabine—colon cancer	0.000156	0.00108	CcSEcCtD
Sparfloxacin—Nausea—Irinotecan—colon cancer	0.000156	0.00108	CcSEcCtD
Sparfloxacin—Back pain—Methotrexate—colon cancer	0.000155	0.00107	CcSEcCtD
Sparfloxacin—Dyspepsia—Capecitabine—colon cancer	0.000154	0.00107	CcSEcCtD
Sparfloxacin—Decreased appetite—Capecitabine—colon cancer	0.000152	0.00106	CcSEcCtD
Sparfloxacin—Pain—Capecitabine—colon cancer	0.00015	0.00104	CcSEcCtD
Sparfloxacin—Constipation—Capecitabine—colon cancer	0.00015	0.00104	CcSEcCtD
Sparfloxacin—Nausea—Fluorouracil—colon cancer	0.000149	0.00103	CcSEcCtD
Sparfloxacin—Ill-defined disorder—Methotrexate—colon cancer	0.000148	0.00103	CcSEcCtD
Sparfloxacin—Feeling abnormal—Capecitabine—colon cancer	0.000144	0.001	CcSEcCtD
Sparfloxacin—Malaise—Methotrexate—colon cancer	0.000144	0.000999	CcSEcCtD
Sparfloxacin—Vertigo—Methotrexate—colon cancer	0.000144	0.000995	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Capecitabine—colon cancer	0.000143	0.000993	CcSEcCtD
Sparfloxacin—Cough—Methotrexate—colon cancer	0.000139	0.000967	CcSEcCtD
Sparfloxacin—Urticaria—Capecitabine—colon cancer	0.000139	0.000965	CcSEcCtD
Sparfloxacin—Body temperature increased—Capecitabine—colon cancer	0.000139	0.00096	CcSEcCtD
Sparfloxacin—Abdominal pain—Capecitabine—colon cancer	0.000139	0.00096	CcSEcCtD
Sparfloxacin—Convulsion—Methotrexate—colon cancer	0.000139	0.00096	CcSEcCtD
Sparfloxacin—Arthralgia—Methotrexate—colon cancer	0.000136	0.000943	CcSEcCtD
Sparfloxacin—Chest pain—Methotrexate—colon cancer	0.000136	0.000943	CcSEcCtD
Sparfloxacin—Myalgia—Methotrexate—colon cancer	0.000136	0.000943	CcSEcCtD
Sparfloxacin—ABCB1—lymph node—colon cancer	0.000135	0.00859	CbGeAlD
Sparfloxacin—Discomfort—Methotrexate—colon cancer	0.000134	0.000932	CcSEcCtD
Sparfloxacin—Confusional state—Methotrexate—colon cancer	0.000132	0.000911	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Methotrexate—colon cancer	0.00013	0.000904	CcSEcCtD
Sparfloxacin—Hypersensitivity—Capecitabine—colon cancer	0.000129	0.000895	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Methotrexate—colon cancer	0.000128	0.000885	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Methotrexate—colon cancer	0.000126	0.000874	CcSEcCtD
Sparfloxacin—Asthenia—Capecitabine—colon cancer	0.000126	0.000871	CcSEcCtD
Sparfloxacin—Anorexia—Methotrexate—colon cancer	0.000124	0.000862	CcSEcCtD
Sparfloxacin—Pruritus—Capecitabine—colon cancer	0.000124	0.000859	CcSEcCtD
Sparfloxacin—Diarrhoea—Capecitabine—colon cancer	0.00012	0.000831	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000119	0.000824	CcSEcCtD
Sparfloxacin—Insomnia—Methotrexate—colon cancer	0.000118	0.000818	CcSEcCtD
Sparfloxacin—Paraesthesia—Methotrexate—colon cancer	0.000117	0.000812	CcSEcCtD
Sparfloxacin—Dyspnoea—Methotrexate—colon cancer	0.000116	0.000806	CcSEcCtD
Sparfloxacin—Somnolence—Methotrexate—colon cancer	0.000116	0.000804	CcSEcCtD
Sparfloxacin—Dizziness—Capecitabine—colon cancer	0.000116	0.000803	CcSEcCtD
Sparfloxacin—Dyspepsia—Methotrexate—colon cancer	0.000115	0.000796	CcSEcCtD
Sparfloxacin—Decreased appetite—Methotrexate—colon cancer	0.000113	0.000786	CcSEcCtD
Sparfloxacin—Pain—Methotrexate—colon cancer	0.000112	0.000773	CcSEcCtD
Sparfloxacin—Vomiting—Capecitabine—colon cancer	0.000111	0.000772	CcSEcCtD
Sparfloxacin—Rash—Capecitabine—colon cancer	0.000111	0.000766	CcSEcCtD
Sparfloxacin—Dermatitis—Capecitabine—colon cancer	0.00011	0.000765	CcSEcCtD
Sparfloxacin—Headache—Capecitabine—colon cancer	0.00011	0.000761	CcSEcCtD
Sparfloxacin—Feeling abnormal—Methotrexate—colon cancer	0.000108	0.000745	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Methotrexate—colon cancer	0.000107	0.000739	CcSEcCtD
Sparfloxacin—Nausea—Capecitabine—colon cancer	0.000104	0.000721	CcSEcCtD
Sparfloxacin—Urticaria—Methotrexate—colon cancer	0.000104	0.000718	CcSEcCtD
Sparfloxacin—Abdominal pain—Methotrexate—colon cancer	0.000103	0.000715	CcSEcCtD
Sparfloxacin—Body temperature increased—Methotrexate—colon cancer	0.000103	0.000715	CcSEcCtD
Sparfloxacin—Hypersensitivity—Methotrexate—colon cancer	9.61e-05	0.000666	CcSEcCtD
Sparfloxacin—Asthenia—Methotrexate—colon cancer	9.36e-05	0.000649	CcSEcCtD
Sparfloxacin—Pruritus—Methotrexate—colon cancer	9.23e-05	0.00064	CcSEcCtD
Sparfloxacin—Diarrhoea—Methotrexate—colon cancer	8.93e-05	0.000618	CcSEcCtD
Sparfloxacin—Dizziness—Methotrexate—colon cancer	8.63e-05	0.000598	CcSEcCtD
Sparfloxacin—Vomiting—Methotrexate—colon cancer	8.3e-05	0.000575	CcSEcCtD
Sparfloxacin—Rash—Methotrexate—colon cancer	8.23e-05	0.00057	CcSEcCtD
Sparfloxacin—Dermatitis—Methotrexate—colon cancer	8.22e-05	0.000569	CcSEcCtD
Sparfloxacin—Headache—Methotrexate—colon cancer	8.17e-05	0.000566	CcSEcCtD
Sparfloxacin—Nausea—Methotrexate—colon cancer	7.75e-05	0.000537	CcSEcCtD
